Dr. Lydia H. Pecker is a pediatric hematologist and Director of the Young Adult Clinic at the Sickle Cell Center for Adults at Johns Hopkins. Dr. Pecker received her undergraduate degree in Africana studies from Brown University and earned her M.D. at the University of Pennsylvania School of Medicine. She completed residency training at Children’s Hospital at Montefiore and completed a fellowship at Children’s National Medical Center and the National Institutes of Health’s National Heart, Lung and Blood Institute before joining the Hopkins faculty in 2016. Dr. Pecker's NIH and foundation-funded research focuses on reproductive health in people with ovaries and sickle cell disease. Dr. Pecker is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Tubal Ligation.

"Dr. James Casella is a professor of pediatrics and oncology at the Johns Hopkins University School of Medicine. As the Johns Hopkins’ Rainey Professor of Pediatric Hematology, Dr. Casella is chief of the Division of Pediatric Hematology at Johns Hopkins Children's and director of the Basic and Translational Research Program in Sickle Cell Disease, Comprehensive Sickle Cell Center and the Maryland Hemophilia Treatment Center at Johns Hopkins. He supervises several labs investigating the cellular and molecular basis of pediatric blood-borne diseases. He is seeking to develop better treatments for sickle cell disease and the prevention of central nervous system complications of this disorder, including stroke. Dr. Casella received his undergraduate degree in mathematics from Union College. He earned his M.D. from SUNY of Syracuse and completed a residency in pediatrics at Johns Hopkins University School of Medicine, where he was subsequently a fellow in hematology/oncology. He has been a member of the Johns Hopkins’ faculty since 1983. A research scientist as well as a clinician, he co-directs the hematology/oncology fellowship program at Johns Hopkins Hospital and is an adjunct senior investigator (Pediatric Oncology Branch) in the Division of Clinical Sciences, National Cancer Institute, National Institutes of Health. He is also director of the NHLBI-funded K12 in benign hematology program at Johns Hopkins that trains young clinician/investigators in benign hematology and transfusion medicine. Dr. Casella has served on numerous university, hospital, and advisory committees, many geared toward hematology, pediatrics and transfusion. He has received many awards from the Johns Hopkins Hospital, including the Alexander ""Buck"" Schaffer Award for Outstanding Contribution to the Teaching of House Officers. He and a colleague created the Johns Hopkins/St. Agnes Comprehensive Hemophilia Clinic to improve care for patients with the disease.". Dr. Casella is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.

Dr. Rakhi P. Naik is the Associate Director for the Division of Hematology at Johns Hopkins University. She also serves as Director of the Fellowship Hematology Track and Director of Organ Systems Foundation of Medicine (OSFM), the largest pre-clerkship course in the medical school. She holds an undergraduate degree in Biomedical & Electrical Engineering from Duke University, an M.D. with. Dr. Naik is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, and Hemoglobinopathy.

Courtney Fitzhugh is a Pediatric Hematologist Oncology provider in Baltimore, Maryland. Dr. Fitzhugh is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant.

Jennie Law is a Hematologist Oncology specialist and a Hospital Medicine provider in Baltimore, Maryland. Dr. Law is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Hemoglobin SC Disease, Hemoglobin E Disease, and Bone Marrow Aspiration. Dr. Law is currently accepting new patients.

Dr. Benjamin Bodnar is an Assistant Professor of Medicine and Pediatrics at the Johns Hopkins School of Medicine. He holds appointments as the Director of Quality and Safety for the Division of Hospital Medicine, Department of Medicine, as a Eudowood Scholar of Quality and Safety in the Division of Quality and Safety, Department of Pediatrics, and is affiliate faculty with the Armstrong Institute for Patient Safety and Quality at Johns Hopkins. He was born and raised in Baltimore and after training in institutions across the country, and working at sites around the world, he has settled back in his hometown. He received his undergraduate degree from Stanford University, his medical degree from Columbia University, and completed his specialty training at Yale New Haven Hospital. He also worked at Brigham and Women’s Hospital in Boston, MA, and held the appointment of an Instructor in Medicine at Harvard Medical School prior to joining Johns Hopkins in 2016. His focus on providing world-class clinical care to his patients at Johns Hopkins Hospital, he has a special interest in global health and the application of Quality Improvement techniques to the often poorly functional systems at work in resource-limited and developing health care environments. He has worked internationally at sites including Nepal, Mongolia, Ghana, Tanzania, Uganda, and Rwanda, and has worked with development groups including Partners in Health and The Millennium Villages Project. He is a faculty member of the Johns Hopkins Center for Global NCD Research and Training. As part of the Johns Hopkins Medicine COVID-19 response, he led the creation of standardized patient care guidelines for non-ICU COVID-19 patients across the health system. He also played a key role in the implementation of these guidelines via an Electronic Medical Record-integrated Clinical Decision Support platform, thus ensuring the evolving guidance is available to all providers at the point of care. Dr. Bodnar is rated as a Distinguished provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Sickle Cell Disease, Hemoglobin C Disease, Hemoglobin E Disease, Endoscopy, and Gastrostomy.

Dr. Helene Hedian is an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine, the Director of Clinical Education at the Johns Hopkins Center for Transgender and Gender Expansive Health, and the Assistant Vice Chair for LGBTQ+ Equity and Education in the Department of Medicine. Her academic interests include internal medicine, medical education, and the specific health needs of LGBTQ patients. Dr. Hedian studied biochemistry and Spanish at the University of Dayton, attended medical school at the University of Maryland School of Medicine, and completed an internal medicine residency at the University of Maryland, where she was selected as a chief resident. She joined the faculty at Johns Hopkins University in 2016. Her research focuses on provider attitudes and knowledge regarding LGBTQ health, with the goal of expanding competent and compassionate healthcare practices. In her clinical practice, she has cared for hundreds of transgender and gender diverse patients. To support primary care providers who prescribe gender-affirming hormones, she authored the Quick Guide: Gender Affirming Hormone Therapy by the Primary Care Provider. As of February 2024, the Quick Guide has been downloaded over 1,500 times and in the following locations: Australia, Canada, Colombia, Czech Republic, Egypt, France, Germany, India, Ireland, Japan, Mexico, Netherlands, New Zealand, Pakistan, Philippines, Poland, Puerto Rico, Russian Federation, Singapore, Thailand, United Kingdom, and the United States. Dr. Hedian is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, and Sickle Cell Disease.

Dr. Jenna V. Canzoniero is an assistant professor in the Breast and Gynecological Malignancies Group at the Johns Hopkins Sidney Kimmel Cancer Center. She is a medical oncologist who specializes in treatment of patients with breast cancer. Dr. Canzoniero earned her medical degree and master's in bioinformatics from University of Michigan. She completed internal medicine residency at University of Maryland and served as Chief Resident. She joined the faculty at Johns Hopkins as an academic Hospitalist before pursuing her passion for oncology. She completed medical oncology fellowship at Johns Hopkins, including serving as Chief Fellow, and then re-joined the faculty as an oncologist. Her research focuses on expanding the use of molecular diagnostics, including liquid biopsy, to guide the treatment for patients with breast cancer. She is the liquid biopsy leader for the Johns Hopkins Molecular Tumor Board and leads the precision medicine initiative for the Breast and Gyn Malignancies Group. Previous awards include Director's Teaching Award in Clinical Science (2023) and the Marion Wright Award for Scientific Excellence (2024) from the Breast Cancer Research Fund. Dr. Canzoniero is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, BRCA Positive Breast Cancer, Breast Cancer, Hemoglobinopathy, and Gastrostomy.

Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy.

Dr. Shruti Chaturvedi is an Associate Professor of Medicine at Johns Hopkins. She received her medical degree from Maulana Azad Medical College, University of Delhi, India. She then completed a residency in Internal Medicine at the Cleveland Clinic, Cleveland, OH, and a fellowship in Hematology and Oncology at Vanderbilt University, Nashville, TN. She has additionally obtained a Master of Science in Clinical Investigation (MSCI) degree from Vanderbilt University. Dr. Chaturvedi specializes in the care of adults with non-malignant hematologic disorders including thrombocytopenic purpura, atypical hemolytic uremic syndrome, antiphospholpiid syndrome, immune thrombocytopenia, autoimmune hemolytic anemia, thrombotic, other bleeding and clotting disorders, and anemias. Her research is focused on improving the care of patients with thrombotic microangiopathies with a focus on long term sequelae, and the role of complement in thrombotic disorders such as the antiphospholipid syndrome. Dr. Chaturvedi is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Blood Clots, Atypical Hemolytic Uremic Syndrome (aHUS), Anemia, Splenectomy, and Bone Marrow Aspiration.

Maria Baer is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Baer is rated as a Distinguished provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Splenectomy. Dr. Baer is currently accepting new patients.

Dr. Bradley C. Strunk is an instructor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is internal medicine. Dr. Strunk is a hospitalist at Johns Hopkins Howard County Medical Center. Dr. Strunk earned his M.D. at Johns Hopkins. He completed his residency at Johns Hopkins Bayview Medical Center. Dr. Strunk is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Sickle Cell Disease, Renovascular Hypertension, Necrosis, Endoscopy, and Ureteroscopy.

Dr. Li Hua is a hospitalist at Johns Hopkins Howard County Medical Center. Dr. Hua only sees patients who are in the hospital, she does not have outpatient clinic appointments. Dr. Hua is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Sepsis, Ogilvie Syndrome, Hip Replacement, and Gastrostomy.

Tara Robinson is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Robinson is rated as a Distinguished provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Hemophilia A, Blood Clots, Hemoglobin SC Disease, and Bone Marrow Transplant.

Dr. Romsai Tony Boonyasai is an assistant professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include hypertension and internal medicine. Dr. Boonyasai serves as medical director of the Johns Hopkins Patient Access Line program. Dr. Boonyasai is an expert on implementing chronic disease improvement programs. He has particular expertise in building programs for improving hypertension control in low-resource settings and for ensuring safe transitions between hospitals and community-based settings. He earned his M.D. from the Mount Sinai School of Medicine. He performed his residency at Baylor College of Medicine and a fellowship in internal medicine at Johns Hopkins. He completed an M.P.H. at the Johns Hopkins Bloomberg School of Public Health. Dr. Boonyasai's research interests include hypertension, quality improvement for chronic disease and care coordination at hospital discharge. As part of Baltimore CONNECT, a partnership between Johns Hopkins and East Baltimore community organizations, Dr. Boonyasai helps project members and community-based leaders connect with hospital staff and leaders. Dr. Boonyasai is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Hypertension and Sickle Cell Disease.

Dr. Ashwini Niranjan-Azadi is an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine. She earned her M.D. from Johns Hopkins and also completed her residency training at Hopkins in the Osler Internal Medicine Residency Program. Dr. Niranjan is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Serum Sickness, Sickle Cell Disease, Cellulitis, Tissue Biopsy, and Liver Transplant.

Dr. William Garneau is a native of Durham, North Carolina. He graduated from Yale University with a degree in English and served as a middle school teacher in the Peace Corps in Namibia. He is a graduate of the University of North Carolina School of Medicine and earned a Master of Public Health at the UNC Gillings School of Global Public Health. He completed internal medicine residency training at the Johns Hopkins Hospital and is an assistant professor of medicine in the Division of Hospital Medicine. In 2023 he received a KL2 mentored Career Development award from the National Institutes of Health. He is currently enrolled in the Graduate Training Program in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Garneau's research uses observational data to study health outcomes including novel therapies and emerging illnesses. His prior research includes studies of mpox and COVID-19. He additionally serves as a lead informaticist with the Critical Path Institute's CURE ID project. His clinical responsibilities include providing direct care to hospitalized patients, serving as a medicine consultant to surgical services, and attending on resident teaching teams. In addition to his clinical work, Dr. Garneau is a Barker Firm Faculty member and teaches students in the Johns Hopkins School of Medicine as well as the Osler Medical Residency Training Program. Dr. Garneau is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Monkeypox, Severe Acute Respiratory Syndrome (SARS), COVID-19, and Syphilis.

Sonia Dalal is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Dalal is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Endoscopy, and Colonoscopy.

Dr. Badaki-Makun's overarching clinical and research focus is on the care of the acutely ill or injured child. Her early research career centered on improving resuscitation outcomes in pediatric patients in cardiopulmonary arrest. For this early work, she was awarded both the American Academy of Pediatrics Ken Graff Young Investigator and the American Heart Association Resuscitation Science Symposium Young Investigator Awards. She continues her work in resuscitation in the clinical and educational arenas. Her recent research centers on enhancing the diagnosis and management of acute complications in patients with sickle cell disease. She is the recipient of a K12 Career Development Award in Hematology for her research dedicated to enhancing the early diagnosis and management of acute chest syndrome in sickle cell patients using novel radiographic and serum biomarkers. As part of this K12 Award, she is completing her PhD in Clinical Investigation at the Graduate Training Program in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Badaki is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sepsis and Sickle Cell Disease.

Dr. Cooke is Director of the Johns Hopkins Kimmel Cancer Center’s Pediatric Bone Marrow Transplantation Program. Prior to his appointment at Johns Hopkins, Dr. Cooke headed the Pediatric Blood and Marrow Transplantation Program at Rainbow Babies and Children’s Hospital, and University Hospitals Case Medical Center, in Cleveland, Ohio. He also co-directed the Hematologic Disorders Program of the Case Comprehensive Cancer Center at Case Western Reserve University. A nationally recognized transplantation immunology expert, Dr. Cooke focuses primarily on new strategies to prevent and treat graft-vs-host disease and lung complications following blood and bone marrow transplantation. His research efforts have been recognized by the Leukemia and Lymphoma Society and the American Society of Clinical Investigation. In addition to his younger patients, Dr. Cooke also cares for adolescents and young adults. Dr. Cooke is rated as an Experienced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Anemia, Aplastic Anemia, and Bone Marrow Transplant.